Denali Therapeutics shares owned by Levin Capital Strategies
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Levin Capital Strategies
from 13F filings
Historical chart of Levin Capital Strategies investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Levin Capital Strategies consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Denali Therapeutics by Levin Capital Strategies
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $794k | 37k | 21.46 |
2023-09-30 | $701k | 34k | 20.63 |
2023-06-30 | $221k | 7.5k | 29.51 |
2022-09-30 | $292k | 9.5k | 30.74 |
2022-06-30 | $222k | 7.5k | 29.60 |